Biomarker-Based Immunoassays Market

The biomarker-based immunoassays market consists of tools, including reagents, kits, instruments, and services, used for early disease detection, monitoring, and personalized treatment. The primary customers are hospitals, diagnostic laboratories, and research institutes. Market growth is propelled by the rising prevalence of chronic diseases, an increase in routine biomarker testing, growing healthcare expenditure, and the adoption of new technologies like AI-assisted analysis and point-of-care testing.